Home/EpiEndo Pharmaceuticals/Hilmar Bragi Janusson, PhD

HB

Hilmar Bragi Janusson, PhD

Chairman of the Board

EpiEndo Pharmaceuticals

Therapeutic Areas

Chronic Obstructive Pulmonary Disease (COPD)Chronic Respiratory Diseases

EpiEndo Pharmaceuticals Pipeline

Drug	Indication	Phase
glasmacinal (EP395)	COPD (Chronic Obstructive Pulmonary Disease)	Phase 1

Leadership Team at EpiEndo Pharmaceuticals

Maria Bech, MSc

Chief Executive Officer

Stefán Pétursson, Cando econ

Chief Financial Officer

Ginny Norris, MRCP

Chief Medical Officer

Finnur Einarsson

Chief Operating Officer

Jennifer Kricker, PhD

Head of Research

View full EpiEndo Pharmaceuticals profile